Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as ... - GlobeNewswire

Submitted by Anonymous (not verified) on Tue, 04/16/2024 - 11:03

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as ...  GlobeNewswire